Best Practice & Research Clinical Endocrinology & Metabolism
Volume 20, Issue 2 , Pages 261-270 , June 2006

Ovulation induction in normogonadotropic anovulation (PCOS)

References 

  1. ESHRE Capri Workshop Group. Mono-ovulatory cycles: a key goal in profertility programmes. Human Reproduction Update. 2003;9:263–274
  2. Insler V, Melmed H, Mashiah S, et al. Functional classification of patients selected for gonadotropic therapy. Obstetrics and Gynecology. 1968;32:620–626
  3. Macklon NS, Fauser BC. Overview of ovulation induction. Up to date online 14.1, 2005.
  4. Stein IF, Leventhal ML. Amenorrhea associated with bilateral polycystic ovaries. American Journal of Gynecologica. 1935;29:181–191
  5. van Santbrink EJ, Hop WC, Fauser BC. Classification of normogonadotrophic anovulatory infertility: polycystic ovaries diagnosed by ultrasound versus endocrine characteristics of polycystic ovary syndrome. Fertility and Sterility. 1997;67:453–458
  6. PCOS consensus . The Rotterdam ESHRE/ASRM-Sponsored PCOS consensus workshop group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Human Reproduction. 2004;19:41–47
  7. PCOS consensus . The Rotterdam ESHRE/ASRM-Sponsored PCOS consensus workshop group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Fertility and Sterility. 2004;81:19–25
  8. van Santbrink EJ, Fauser BC. Is there a future for ovulation induction in the current era of assisted reproduction?. Human Reproduction. 2003;18:2499–2502
  9. Aboulghar MA, Mansour RT. Ovarian hyperstimulation syndrome: classifications and critical analysis of preventive measures. Human Reproduction Update. 2003;9:275–289
  10. Fauser BC, Devroey P, Macklon NS. Multiple birth resulting from ovarian stimulation for subfertility treatment. Lancet. 2005;365:1807–1816
  11. Eijkemans MJ, Polinder S, Mulders AG, et al. Individualized cost-effective conventional ovulation induction treatment in normogonadotrophic anovulatory infertility (WHO2). Human Reproduction. 2005;20:2830–2837
  12. Kiddy DS, Hamilton-Fairley D, Bush A, et al. Improvement in endocrine and ovarian function during dietary treatment of obese women with polycystic ovary syndrome. Clinical Endocrinology. 1992;36:105–111
  13. Clark AM, Thornley B, Tomlinson L, et al. Weight loss in obese infertile women results in improvement of reproductive outcome for all forms of fertility treatment. Human Reproduction. 1998;13:1502–1505
  14. Imani B, Eijkemans MJ, te Velde ER, et al. Predictors of patients remaining anovulatory during clomiphene citrate induction of ovulation in normogonadotropic oligoamenorrheic infertility. The Journal of Clinical Endocrinology and Metabolism. 1998;83:2361–2365
  15. Imani B, Eijkemans MJ, Faessen G, et al. Prediction of the individual FSH-threshold for gonadotrophin induction of ovulation in anovulatory infertility: an approach to minimize multiple gestation, ovarian hyperstimulation, and treatment expense. Fertility and Sterility. 2002;77:83–90
  16. Mulders AG, Eijkemans MJ, Imani B, Fauser BCJM. Prediction of chances for success or complications in gonadotrophin ovulation induction in normogonadotrophic anovulatory infertility. Reproductive Biomedicine Online. 2003;7:48–56
  17. Eijkemans MJ, Imani B, Mulders AG, et al. High singleton live birth rate following classical ovulation induction in normogonadotropic anovulatory infertility. Human Reproduction. 2003;18:2357–2362
  18. Norman RJ, Davies MJ, Lord J, Moran LJ. The role of lifestyle modification in polycystic ovary syndrome. Trends in Endocrinology and Metabolism: TEM. 2002;13:251–257
  19. Wu CH, Winkel CA. The effect of therapy initiation day on CC therapy. Fertility and Sterility. 1989;52:564–568
  20. Kousta E, White DM, Franks S. Modern use of CC in induction of ovulation. Human Reproduction Update. 1997;3:359–365
  21. Imani B, Eijkemans MJ, te Velde ER, et al. Predictors of chances to conceive in ovulatory patients during clomiphene citrate induction of ovulation in normogonadotropic oligoamenorrheic infertility. The Journal of Clinical Endocrinology and Metabolism. 1999;84:1617–1622
  22. Imani B, Eijkemans MJ, te Velde ER, et al. A nomogram to predict the probability of live birth after clomiphene citrate induction of ovulation in normogonadotropic oligoamenorrheic infertility. Fertility and Sterility. 2002;77:91–97
  23. Dunaif A. Insulin resistance and the polycystic ovary syndrome: mechanisms and implications for pathogenesis. Endocrine Reviews. 1997;18:774–800
  24. Coffler MS, Patel K, Dahan MH, et al. Enhanced granulosa cell responsiveness to FSH during insulin infusion in women with PCOS treated with Pioglitazone. The Journal of Clinical Endocrinology and Metabolism. 2003;88:5624–5631
  25. Nestler JE, Jakubowicz DJ, Evans WS, Pasquali R. Effects of metformin on spontaneous and clomiphene-induced ovulation in the polycystic ovary syndrome. The New England Journal of Medicine. 1998;338:1876–1880
  26. Lord JM, Flight IHK, Norman RJ. Metformin in polycystic ovary syndrome: systematic review and meta-analysis. British Medical Journal. 2003;327:951–953
  27. Kashyap S, Wells GA, Rosenwaks Z. Insulin-sensitizing agents as primary therapy for patients with polycystic ovary syndrome. Human Reproduction. 2004;19:2474–2483
  28. Glueck CJ, Goldenberg N, Pranikoff J, et al. Height, weight and motor-social development during the first 18 months of life in 126 infants born to 109 mothers with polycystic ovary syndrome who conceived on and continued metformin through pregnancy. Human Reproduction. 2004;19:1323–1330
  29. Costello MF, Eden JA. A systematic review of the reproductive system effects of Metformine in patients with PCOS. Fertility and Sterility. 2003;79:1–13
  30. de Leo V, la Marca A, Ditto A, et al. Effects of metformin on gonadotropin-induced ovulation in women with polycystic ovary syndrome. Fertility and Sterility. 1999;72:282–285
  31. Yarali H, Yildiz BO, Demirol A, et al. Co-administration of metformin during rFSH treatment in patients with clomiphene citrate-resistant polycystic ovarian syndrome: a prospective randomized trial. Human Reproduction. 2002;17:289–294
  32. van Santbrink EJ, Hohmann FP, Eijkemans MJ, et al. Does Metformin modify ovarian responsiveness during exogenous FSH ovulation induction in normogonadotrophic anovulation? A placebo controlled double blind assessment. European Journal of Endocrinology. 2005;152:611–617
  33. Mitwally MFM, Casper RF. Aromatase inhibitors for the treatment of infertility. Expert Opinion on Investigational Drugs. 2003;12:353–371
  34. Fatemi HM, Kolibianakis E, Tournaye H, et al. Clomiphene citrate versus letrozole for ovarian stimulation: a pilot study. Reproductive Biomedicine Online. 2003;7:543–546
  35. Fisher SA, Reid RL, van Vught DA, Casper RF. A randomized double blind comparison of the effects of CC and the aromatase inhitor Letrozole on the ovulatory function in normal women. Fertility and Sterility. 2002;78:280–285
  36. Greenblatt E, Casper RF. Endocrine changes after laparoscopic ovarian cautery in polycystic ovary syndrome. American Journal of Obstetrics and Gynecology. 1987;156:279–285
  37. Gjonnaess H. Polycystic ovarian syndrome treated by ovarian electrocautery through the laparoscope. Fertility and Sterility. 1984;41:20–25
  38. Farquhar C, Vandekerckhove P, Lilford L. Laparascopic ‘drilling'by diahermie or laser for ovulation induction in anovulatory polycystic ovary syndrome. Cochrane Database of Systematic Reviews. 2001;4
  39. Bayram N, van Wely M, Kaayk EM, et al. Using an electrocautery strategy or recombinant follicle stimulating hormone to induce ovulation in polycystic ovary syndrome: randomised controlled trial. British Medical Journal. 2004;328:192–195
  40. Amer SA, Li TC, Ledger WL. Ovulation induction using laparoscopic ovarian drilling in women with PCOS: predictors of success. Human Reproduction. 2004;19:1719–1724
  41. Van Wely M, Bayram N, van der Veen F, Bossuy PM. Predictors for treatment failure after laparoscopic electrocautery of the ovaries in women with clomiphene citrate resistant PCOS. Human Reproduction. 2005;20:900–905
  42. Palomba S, Orio F, Nardo LG, et al. Metformin administration versus laparoscopic ovarian diathermy in clomiphene citrate-resistant women with PCOS: a prospective parallel randomized double-blind placebo-controlled trial. The Journal of Clinical Endocrinology and Metabolism. 2004;89:4801–4809
  43. Fauser BC, van Heusden AM. Manipulation of human ovarian function: physiological concepts and clinical consequences. Endocrine Reviews. 1997;18:71–106
  44. White DM, Polson DW, Kiddy D, et al. Induction of ovulation with low-dose gonadotropins in polycystic ovary syndrome: an analyisof 109 pregnancies in 225 women. The Journal of Clinical Endocrinology and Metabolism. 1996;81:3821–3824
  45. van Santbrink EJ, Donderwinkel FJ, Van Dessel HJ, Fauser BC. Gonadotrophin induction of ovulation using a step-down dose regimen: single-center clinical experience in 82 patients. Human Reproduction. 1995;10:37–43
  46. van Santbrink EJ, Fauser BC. Urinary follicle-stimulating hormone for normogonadotropic clomiphene-resistant anovulatory infertility: Prospective, randomized comparison between low-dose step-up and step-down dose regimens. The Journal of Clinical Endocrinology and Metabolism. 1997;82:3597–3602
  47. Balash J, Fabregues F, Creus M, et al. Follicular development and hormone concentrations following recFSH administration for anovulation associated with polycystic ovary syndrome: prospective, randomized comparison between low-dose step-up and modified step-down regimens. Human Reproduction. 2001;16:652–656
  48. Christin-Maitre S, Hugues JN. A comparative randomized multicentric study comparing the step-up versus step-down protocol in polycystic ovary syndrome. Human Reproduction. 2003;18:1626–1631
  49. van Santbrink EJ, Eijkemans MJ, Laven SJ, Fauser BC. Patient-tailored conventional ovulation induction algorithms in anovulatory infertility. Trends in Endocrinology and Metabolism: TEM. 2005;16:381–389
  50. van Santbrink EJ, Eijkemans MJ, Macklon NS, Fauser BC. FSH response-dose can be predicted in ovulation induction for normogonadotropic anovulatory infertility. European Journal of Endocrinology. 2002;147:223–226

PII: S1521-690X(06)00024-8

doi: 10.1016/j.beem.2006.03.002

Best Practice & Research Clinical Endocrinology & Metabolism
Volume 20, Issue 2 , Pages 261-270 , June 2006

Article Tools

* Image Usage & Resolution